Hi LynEyre,
Many thanks for your reply. Yes things are a bit muddled from my viewpoint. I am not aware of any medical conditions which might preclude future radiotherapy and nothing has been disclosed to me about other problems. Yes my case is discussed by an MDTeam and there has be opinions expressed by Onco's to Urologists on the team but I am not copied in on decisions.
My concerns are that having been a year on Zoladex, the good news is that Psa has progressively dropped from 264 to 6.3, but some assumptions about PCa spread are being made without proper investigation. I am otherwise fit apart from advertised Zoladex side effects.
I was told a year ago by my urologist I had a "Gleason 7 Pca with a negative bone scan" and that " due to the high PSA count at outset (264) RT was inappropriate" All blood tests so far Ok. I have asked if my Pca has been graded and I have no info on that yet. Also there have been no further investigations into mets or spread since Jan 2014. Current plan is continue with Zoladex HT TFN.
I have asked, in view of a negative bone scan in Jan 2014, how spread to Lymph nodes and Bones might be detected without an MRI scan. I am advised; if I present with other symptoms via my GP then issues will be dealt with then. No MRI scan is currently on offer.
I chatted with the specialist nurse on this forum, and she agreed, my PCa should be properly graded and an MRI scan should be in the plan. Also if you look at the posts from folk on the website, there is some consensus that HT, a scan followed by RT seems a coherent plan for those with similar outlooks.
I probably need to be a bit more pushy at the next appointment, Suffice it to say, I hope to see an Onco face to face. The issues discussed above have been raised with professionals at the NHS trust at each consultation. In short I am hoping my treatment will become more proactive.
Many thanks, I post a note after my next appointment and all know the grand plan.
Regards Geronimo
I